Ajouter un événement
Annoncer / Référencer
SPECIALITES MEDICALES ...

Promotion & Advertising Practices 2018 under FDA Observation

Du Jeudi 17 Mai 2018 au Vendredi 18 Mai 2018 à PA
A partir de: 09:00
Secteurs concernés: Biologie -Biomedical -Biotechnologie -
DESCRIPTION
Course "FDA Scrutiny of Promotion and Advertising Practices" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:
If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are loathe to even consult with each other.
FDA's Center for Devices and Radiological Health (CDRH) has never issued a comprehensive guidance on advertising and promotion. You are on your own. In contrast, FDA's Center for Drug Evaluation and Research (CDER) uses long-standing regulations and a growing number of guidance documents in its regulatory approach. Policing social media has become a new regulatory responsibility and FDA is still trying to figure out how to deal with it. Bottom line, do you know when you fail to meet FDA's requirements or are you guessing? Can you afford to guess? The cost to your business and the confusion left in your customers' mind becomes an unwelcomed nightmare.
In this seminar, you will learn how to navigate FDA's numerous legal options and how to interpret them based on basic legal principles. Applying new guidance documents becomes a new test of the FDA's legal boundaries and enforcement options. The agency is now conducting clinical studies and applies the principles of cognitive psychology to aid in its determination of what a message really conveys. This academic discipline may or may not get to the root of what consumers take away as the message.
Congress and the new FDA Commissioner seem more sympathetic to expanding access to medical treatment before all the conclusive evidence for safety and effectiveness is evaluated by the FDA. Valid off-label information may take the lead in that direction.
This conference will provide insight on how to manage your marketing activity and gauge what regulatory risks your business is willing to accept. You will learn how corporate management requires cooperation between marketing, regulatory affairs, legal counsel, manufacturing, engineering and finance departments. Operating in a stovepipe environment will not work. You need to understand that a weak link in any department leaves the entire corporation vulnerable to FDA enforcement. Most importantly, you will understand the boundaries that FDA uses and how easy it is to cross them. With information from this course, you can step back and rationally evaluate your firm's regulatory profile for advertising and promotion practices.
________________________________________
Learning Objective:
• Learn how FDA faces constitutional constraints on enforcement decisions
• Learn about intersecting federal requirements by the Department of Justice, the Federal Trade Commission, the Securities and Exchange Commission and the Consumer Product Safety Commission
• Learn how the FDA interprets advertising and promotion in principle and in fact
• Understand ways that a firm violates FDA requirements
• Evaluate advertising and promotional material based on interactive group hypotheticals
• See how sales and marketing departments play a central role, for better or worse
• Learn how the federal government holds executive management responsible for missteps in promotion and advertising practices.
________________________________________
Who Will Benefit:
• Sales and Marketing executives and managers
• Regulatory Managers
• In-house Legal Counsel and Contract Specialists
• 3rd party consultants
• Venture Capitalists
• Investors
• Business Acquisition Executives
• Owners of New or Developing Firms
• Own label distributors
• International Trade Managers
• Product specification developers
________________________________________
Background
FDA regulates advertising and promotion material as labeling. The legal definition of labeling covers just about anything that explicitly or implicitly conveys a message intended to affect a person's behavior and decision outcomes. The vehicle for communication has evolved dramatically over the past 100 years and continues to evolve at a rate faster than one can anticipate at times. How FDA applies its legal tenants of false and misleading information or variations on that theme requires continual updating by FDA and constant re-evaluation by industry. Now the legal field playing field involves other federal agencies and departments, and they work in concert with FDA. It has become very complicated and very costly if you knowingly or unknowing walk into a legal snare. This seminar is designed to bring you up to speed so you are clearer about what is a problem, what is not a problem and what becomes a risk laden judgment call.
Agenda:

Day 1 Schedule
________________________________________
8:30 AM - 9:00 AM: Registration
________________________________________
9:00 AM - 10:30 AM
Lecture 1: FDA legal authority
• FDA application of the FD&C Act and implementing regulations
• FTC / mass media
• SEC/False statements
• DOJ / False Claims
• Enforcement authority and options
Cognitive psychology vs. psychoanalytic motivation
________________________________________
10:30 AM - 12:00 PM
Lecture 2: Promotion and Advertising: scope of labeling
• Definitions for "label" and "labeling"
• Hard copy and electronic
• Testimonials
• Blogs
• Sales force
• What is "off-label?"
• Practice of Medicine exemption
• Drugs authority
• Devices
• Dietary supplements
________________________________________
12:00 PM - 1:00 PM Lunch
________________________________________
1:00 PM - 2:30 PM
Lecture 3: Supreme Court / commercial free speech
• Constitutional protection and case law
• Amarin Case: off-label, but true
• Safe harbor
Policy
• FDA organizational responsibility
• FDA Guidance
________________________________________
2:30 PM - 2:45 PM Break
________________________________________
2:45 PM - 4:30 PM
• Fair and balanced disclosure
• Social media
• Direct to Consumer Advertising
Hypothetical Workshop
Day 2 Schedule
________________________________________
9:00 AM - 10:30 AM
Lecture 1:
Direct to consumer advertising vectors
Federal Trade Commission interest (economic vs. safety)
Context and format of messaging
Script versus message
• Target population
• Aspirations
• Emotional factors
________________________________________
10:30 AM - 12:00 PM
Lecture 2: False and misleading information
• Statutory basis (21 U.S.C. 352(a))
• New use
• Comparative claims
• Claims for safety and effectiveness
• Sales for solicitation
________________________________________
12:00 PM - 1:00 PM Lunch
________________________________________
1:00 PM - 2:30 PM
Lecture 3:
Off label use - practices and policy
FDA Warning Letters
________________________________________
2:30 PM - 2:45 PM Break
________________________________________
2:45 PM - 4:30 PM
Lecture 4:
Practice of medicine exemption
Custom Device promotion
(Group Hypothetical)
Corporate management responsibility
Speaker
Casper Uldriks
ex-FDA Expert and former Associate Center Director of CDRH


Casper (Cap) Uldriks owns Encore Insight LLC, which provides consulting services on FDA Law. He brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and as an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. He is recognized as an exceptional and energetic speaker. His comments are candid, straightforward and of practical value. He understands how FDA thinks, operates and where it is headed.

Location:  Philadelphia, PA Date: May 17th & 18th, 2018 and Time: 9:00 AM to 4:30 PM
Venue:  DoubleTree by Hilton Philadelphia Airport 4509 Island Avenue, Philadelphia, PA 19153
Price:
Price: $1,295.00 (Seminar Fee for One Delegate)
Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*
Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*
Register now and save $200. (Early Bird)
Until April 10, Early Bird Price: $1,295.00 From April 11 to May 15, Regular Price: $1,495.00
Sponsorship Program benefits for “FDA Scrutiny of Promotion and Advertising Practices” seminar
For More Information- https://www.globalcompliancepanel.com/control/sponsorship 
Contact us today!
NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com  
support@globalcompliancepanel.com 
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901417SEMINAR?SEO
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel
PUBLIC, SECTEURS, ACCREDITATION
Accréditations : 0
Public concerné: Professionnel
Audience: Internationnale
Visiteurs/Participants: 50
Conférenciers: 1
Exposants: 1
Type d'événement: Colloque
Secteur principal: BIOLOGIE
Secteurs concernés: Biologie -Biomedical -Biotechnologie -
ORGANISATEUR / ANNONCEUR

NETZEALOUS LLC - GLOBALCOMPLIANCEPANEL
161 Mission Falls Lane, Suite 216
94539 Fremont
UNITED STATES

COMMENT
REFERENCE
Congrès, formations ou conférences médicales REF #28-7979
Promotion & Advertising Practices 2018 under FDA Observation
Publié sur congres-medical.com le : 2018-04-05 11:13:39
Congrès, formations ou conférences médicales en BIOLOGIE
Affiche / Visuel
RESERVATIONS HOTELS: PA
Obtenez les meilleures offres
sur les hôtels!
près de DoubleTree by Hilton Philadelphia Airport

Recherche d'hôtels

Date d'arrivée

Date de départ

VOTEZ
Evaluez cette annonce
PREPAREZ VOTRE VOYAGE
Liens extérieurs sponsorisés
;
Plus d'information sur le HONcode